annual cash & cash equivalents:
$13.77B+$6.60B(+92.22%)Summary
- As of today (August 21, 2025), MRK annual cash & cash equivalents is $13.77 billion, with the most recent change of +$6.60 billion (+92.22%) on December 31, 2024.
- During the last 3 years, MRK annual cash & cash equivalents has risen by +$5.67 billion (+70.02%).
- MRK annual cash & cash equivalents is now -21.28% below its all-time high of $17.49 billion, reached on December 31, 2013.
Performance
MRK Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$8.66B-$666.00M(-7.14%)Summary
- As of today (August 21, 2025), MRK quarterly cash & cash equivalents is $8.66 billion, with the most recent change of -$666.00 million (-7.14%) on June 30, 2025.
- Over the past year, MRK quarterly cash & cash equivalents has dropped by -$2.73 billion (-23.96%).
- MRK quarterly cash & cash equivalents is now -61.07% below its all-time high of $22.26 billion, reached on September 30, 2009.
Performance
MRK quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MRK Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +92.2% | -24.0% |
| 3 y3 years | +70.0% | -15.1% |
| 5 y5 years | +31.7% | -22.0% |
MRK Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +92.2% | -40.8% | +51.7% |
| 5 y | 5-year | at high | +92.2% | -40.8% | +51.7% |
| alltime | all time | -21.3% | +1749.4% | -61.1% | +1603.4% |
MRK Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $8.66B(-7.1%) |
| Mar 2025 | - | $9.33B(-32.2%) |
| Dec 2024 | $13.77B(+92.2%) | $13.77B(-5.9%) |
| Sep 2024 | - | $14.63B(+28.4%) |
| Jun 2024 | - | $11.40B(+99.5%) |
| Mar 2024 | - | $5.71B(-20.2%) |
| Dec 2023 | $7.16B(-46.0%) | $7.16B(-18.7%) |
| Sep 2023 | - | $8.81B(+37.2%) |
| Jun 2023 | - | $6.42B(-38.4%) |
| Mar 2023 | - | $10.42B(-21.5%) |
| Dec 2022 | $13.27B(+63.9%) | $13.27B(+16.6%) |
| Sep 2022 | - | $11.38B(+11.5%) |
| Jun 2022 | - | $10.21B(+13.6%) |
| Mar 2022 | - | $8.99B(+11.0%) |
| Dec 2021 | $8.10B(+0.6%) | $8.10B(-19.2%) |
| Sep 2021 | - | $10.02B(+16.8%) |
| Jun 2021 | - | $8.57B(+22.8%) |
| Mar 2021 | - | $6.98B(-13.3%) |
| Dec 2020 | $8.05B(-23.0%) | $8.05B(+9.4%) |
| Sep 2020 | - | $7.36B(-33.7%) |
| Jun 2020 | - | $11.10B(+49.4%) |
| Mar 2020 | - | $7.43B(-28.9%) |
| Dec 2019 | $10.45B(+17.9%) | $10.45B(+30.3%) |
| Sep 2019 | - | $8.02B(+12.9%) |
| Jun 2019 | - | $7.11B(-19.2%) |
| Mar 2019 | - | $8.80B(-0.7%) |
| Dec 2018 | $8.86B(+4.3%) | $8.86B(-13.8%) |
| Sep 2018 | - | $10.29B(+35.4%) |
| Jun 2018 | - | $7.59B(+3.4%) |
| Mar 2018 | - | $7.35B(-13.6%) |
| Dec 2017 | $8.50B(-40.7%) | $8.50B(-24.1%) |
| Sep 2017 | - | $11.20B(-6.5%) |
| Jun 2017 | - | $11.97B(-21.5%) |
| Mar 2017 | - | $15.25B(+6.3%) |
| Dec 2016 | $14.34B(+6.8%) | $14.34B(+9.7%) |
| Sep 2016 | - | $13.07B(+10.4%) |
| Jun 2016 | - | $11.83B(-8.6%) |
| Mar 2016 | - | $12.94B(-3.6%) |
| Dec 2015 | $13.43B(-14.6%) | $13.43B(+11.1%) |
| Sep 2015 | - | $12.09B(+6.3%) |
| Jun 2015 | - | $11.37B(-27.1%) |
| Mar 2015 | - | $15.60B(-0.8%) |
| Dec 2014 | $15.72B(-10.1%) | $15.72B(+9.6%) |
| Sep 2014 | - | $14.35B(+7.1%) |
| Jun 2014 | - | $13.39B(-34.7%) |
| Mar 2014 | - | $20.51B(+17.3%) |
| Dec 2013 | $17.49B(+8.3%) | $17.49B(-3.8%) |
| Sep 2013 | - | $18.17B(+0.4%) |
| Jun 2013 | - | $18.10B(+13.0%) |
| Mar 2013 | - | $16.02B(-0.7%) |
| Dec 2012 | $16.14B(+7.8%) | $16.14B(-10.9%) |
| Sep 2012 | - | $18.12B(+3.8%) |
| Jun 2012 | - | $17.45B(+12.1%) |
| Mar 2012 | - | $15.57B(+4.0%) |
| Dec 2011 | $14.97B(+22.7%) | $14.97B(-3.9%) |
| Sep 2011 | - | $15.58B(+11.4%) |
| Jun 2011 | - | $13.98B(+7.3%) |
| Mar 2011 | - | $13.03B(+6.8%) |
| Dec 2010 | $12.20B(+27.0%) | $12.20B(+14.8%) |
| Sep 2010 | - | $10.62B(+6.9%) |
| Jun 2010 | - | $9.94B(+1.7%) |
| Mar 2010 | - | $9.78B(+1.8%) |
| Dec 2009 | $9.60B | $9.60B(-56.8%) |
| Sep 2009 | - | $22.26B(+31.4%) |
| Jun 2009 | - | $16.93B(+34.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $12.58B(+129.3%) |
| Dec 2008 | $5.49B(-33.3%) | $5.49B(-19.8%) |
| Sep 2008 | - | $6.84B(-31.5%) |
| Jun 2008 | - | $9.99B(+9.0%) |
| Mar 2008 | - | $9.16B(+11.3%) |
| Dec 2007 | $8.23B(-5.5%) | $8.23B(+11.4%) |
| Sep 2007 | - | $7.39B(+34.3%) |
| Jun 2007 | - | $5.50B(+35.7%) |
| Mar 2007 | - | $4.06B(-53.4%) |
| Dec 2006 | $8.71B(-44.3%) | $8.71B(-4.1%) |
| Sep 2006 | - | $9.09B(-13.2%) |
| Jun 2006 | - | $10.46B(-15.6%) |
| Mar 2006 | - | $12.40B(-20.7%) |
| Dec 2005 | $15.64B(+120.6%) | $15.64B(+11.5%) |
| Sep 2005 | - | $14.03B(+7.7%) |
| Jun 2005 | - | $13.03B(+38.1%) |
| Mar 2005 | - | $9.44B(+149.7%) |
| Dec 2004 | $7.09B(+69.9%) | - |
| Dec 2003 | $4.17B(-16.1%) | - |
| Dec 2002 | $4.97B(+51.3%) | - |
| Dec 2001 | $3.29B(-22.8%) | - |
| Dec 2000 | $4.25B(+272.1%) | - |
| Sep 1999 | - | $3.78B(+6.7%) |
| Jun 1999 | - | $3.54B(+14.4%) |
| Mar 1999 | - | $3.10B(-22.9%) |
| Sep 1998 | - | $4.01B(+42.9%) |
| Mar 1998 | - | $2.81B(+149.7%) |
| Dec 1997 | - | $1.13B(-12.2%) |
| Sep 1997 | - | $1.28B(-19.2%) |
| Jun 1997 | - | $1.59B(-8.6%) |
| Mar 1997 | - | $1.74B(+28.4%) |
| Dec 1996 | - | $1.35B(+0.6%) |
| Sep 1996 | - | $1.34B(-20.3%) |
| Jun 1996 | - | $1.69B(-3.8%) |
| Mar 1996 | - | $1.75B(-5.1%) |
| Dec 1995 | - | $1.85B(-3.1%) |
| Sep 1995 | - | $1.91B(+14.5%) |
| Jun 1995 | - | $1.66B(-25.1%) |
| Mar 1995 | - | $2.22B(+38.5%) |
| Dec 1994 | - | $1.60B(+32.2%) |
| Sep 1994 | - | $1.21B(-0.5%) |
| Jun 1994 | - | $1.22B(+33.0%) |
| Mar 1994 | - | $917.00M(+10.6%) |
| Dec 1993 | - | $829.40M(-30.7%) |
| Sep 1993 | - | $1.20B(+41.2%) |
| Jun 1993 | - | $847.80M(+20.7%) |
| Mar 1993 | - | $702.50M(+22.2%) |
| Dec 1992 | - | $575.10M(-33.8%) |
| Sep 1992 | - | $868.80M(+21.4%) |
| Jun 1992 | - | $715.90M(+3.0%) |
| Mar 1992 | - | $694.80M(-12.9%) |
| Dec 1991 | - | $797.90M(-13.3%) |
| Sep 1991 | - | $920.30M(+28.1%) |
| Jun 1991 | - | $718.20M(-7.8%) |
| Mar 1991 | - | $779.20M(-3.4%) |
| Dec 1990 | - | $806.40M(+24.5%) |
| Sep 1990 | - | $647.60M(+15.5%) |
| Jun 1990 | - | $560.80M(+10.2%) |
| Mar 1990 | - | $508.70M(-25.7%) |
| Dec 1989 | $1.14B(-26.2%) | $685.10M(+9.8%) |
| Sep 1989 | - | $623.80M(-59.8%) |
| Dec 1988 | $1.55B(+35.0%) | $1.55B(+35.0%) |
| Dec 1987 | $1.15B(+18.9%) | $1.15B(+18.9%) |
| Dec 1986 | $965.80M(+14.7%) | $965.80M(+14.7%) |
| Dec 1985 | $842.00M(+13.1%) | $842.00M(+13.1%) |
| Dec 1984 | $744.30M | $744.30M |
FAQ
- What is Merck & Co., Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Merck & Co., Inc.?
- What is Merck & Co., Inc. annual cash & cash equivalents year-on-year change?
- What is Merck & Co., Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Merck & Co., Inc.?
- What is Merck & Co., Inc. quarterly cash & cash equivalents year-on-year change?
What is Merck & Co., Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MRK is $13.77B
What is the all time high annual cash & cash equivalents for Merck & Co., Inc.?
Merck & Co., Inc. all-time high annual cash & cash equivalents is $17.49B
What is Merck & Co., Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MRK annual cash & cash equivalents has changed by +$6.60B (+92.22%)
What is Merck & Co., Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MRK is $8.66B
What is the all time high quarterly cash & cash equivalents for Merck & Co., Inc.?
Merck & Co., Inc. all-time high quarterly cash & cash equivalents is $22.26B
What is Merck & Co., Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MRK quarterly cash & cash equivalents has changed by -$2.73B (-23.96%)